Skip to main content

Table 4 Prediction of Emini surface accessibility for the accessible region

From: Immunoinformatics approach to epitope-based vaccine design against the SARS-CoV-2 in Bangladeshi patients

Start

End

Peptide

Length

113

121

LQSYGFQPT

9

220

228

LQYGSFCTQ

9

284

292

VLSFELLHA

9

302

310

VVVLSFELL

9

562

570

AAYYVGYLQ

9

590

598

AVLYQDVNC

9

48

56

AYSNNSIAI

9

92

100

CVADYSVLY

9

412

420

CVIAWNSNN

9

890

898

CVLGQSKRV

9

131

139

FAMQMAYRF

9

902

910

DVVNQNAQA

9

966

974

AYRFNGIGV

9